Efavirenz and CYP2B6: What All HIV Patients Need to Know
Efavirenz has helped millions of people living with HIV achieve viral suppression, especially in countries where access to newer antiretroviral drugs remains limited….
-
-
Guarding Against Chemotherapy Toxicity: The Promise of Helix’s DPYD Test
The key lies in the DPYD gene, which produces an enzyme called DPD that helps the body break down and clear fluoropyrimidines.
-
How Much Does a Pharmacogenomics Test Cost? What You Need to Know Before You Pay
How much does PGx cost?
-
Should You Take a Pharmacogenomics Test at Home? Here’s What to Know Before You Swab
With the rise of direct-to-consumer (DTC) options, more people are exploring whether they should take a pharmacogenomics test at home to understand how their genes affect their response to medications.
-
So You Want To Take That Genetic Test, Have You Considered These 5 Things?
Genetic testing is now a common part of medical care. It helps explain health problems, guide treatment, and identify risks for certain conditions….
-
Could One Gene Predict MS Treatment Success? A New Study Says Yes, for This Drug
The study, published in the European Journal of Neurology, looked at a single genetic variant—rs7665090—and found that it may predict how well patients respond to interferon-beta (IFNβ) [1], one of the most commonly used MS drugs. And the results were quite unexpected.
-
The Right Drug Dose Now Act: What Healthcare Professionals Need to Know
In March 2025, U.S. Representatives Dan Crenshaw (R-TX) and Eric Swalwell (D-CA) introduced a bipartisan bill that could reshape how medication is prescribed across the country. Known as the Right Drug Dose Now Act, the legislation aims to formally integrate pharmacogenomic (PGx) testing into routine healthcare by updating the National Action Plan for Adverse Drug Event Prevention.
-
Precision Nutrition and PGx: The Untapped Market for Food and Supplement Companies
Explore the untapped market of Precision Nutrition and PGx for food, beverage, and supplement companies. Develop targeted products with PGx insights.
-
Betelgeuse Is Here. Now Let’s Talk About the Real Problem
But here’s the uncomfortable truth: models like Betelgeuse need a healthcare system that can keep up, and right now, we don’t have one.
-
Pharmacogenomics in the Workplace: A New Frontier for Employee Wellness Programs
See how incorporating Pharmacogenomics in the Workplace into corporate wellness initiatives enhances employee health outcomes and cuts costs in our case study.
End of content
End of content